whooping cough logo

How much protection does immunization give

Home page

Quick self-diagnosis test

Introduction from Dr Doug Jenkinson

Symptoms (sounds and video)


Laboratory diagnosis



Who catches it?

How do you catch it?


A printout for your doctor


Send a comment to Dr J

Keyworth study of whooping cough

About Dr Doug Jenkinson

Sufferers' comments and experiences


Extra material

Updated December 2018

Good protection for about 3 years with acellular vaccine (DTaP, TdaP).

Immunization gives a certain amount of protection to an individual but a great deal more  to the population as a whole. And whether somebody who has been immunized gets whooping cough or not depends on a great many other factors as well. Vaccine manufacturers tend to quote protection levels of about 80%. But if immunization fails to protect an individual the severity is always less than being unimmunized.

Most people are surprised when an immunized individual gets it. But it should not cause surprise. It is a complex organism which needs to be attacked in several different ways at once to stop it infecting. Whether you get it or not depends primarily on whether you come into contact with it. If everybody else has been immunized then the bug never gets much of a chance to spread itself around, so you may never come into contact with it. If nobody is immunized then it will always be around and you will come into contact with it so often that even if you have been immunized you will get it sooner or later when your immunity diminishes or resistance is lowered by having a cold or other respitatory infection.

Nobody has been able to measure the effectiveness of the vaccine precisely because it depends on the ability of the bug to spread itself around. This will depend to an extent on how many people have natural immunity and how many have vaccine immunity which is possibly not so good. The number of people with natural immunity is probably getting less as the pre-immunization generation gets older, but some of the immunized ones will perhaps get an unnoticed boost from natural infection if it comes back a bit. So it is all complex, and there is no good way of measuring susceptibility by measuring antibodies as it is also so complex.

What we do know is that when a population of children gets immunized the number of cases falls dramatically, and it is enough to ask of a vaccine that it should do that. It is also generally agreed that individual protection falls quite rapidly after the last shot, so that 5 years later the amount of protection may have fallen to quite a low level.

Research suggests that acellular pertussis vaccines do not give as good protection as the older whole cell vaccines. As a very rough rule of thumb, you could say the old vaccine is effective for up to 10 years and the newer ones up to 5 years. But this is a great simplification of a complex issue. It is also likely that the newer vaccines are not so good at preventing colonisation of the respiratory tract by pertussis and this may create greater risk of transmission.

It seems that to a significant extent it we can say that immunization can prevent the disease but not necessarily the infection. This area is being extensively researched.

The main purpose of immunization is to stop young babies getting it because they can die. So as long as their older brothers and sisters are protected by immunization they are relatively safe. But because adults may not be getting their faded immunity boosted by natural infection, some of them are getting it and passing it to their children! Most immunization programs now have 3 shots in infancy and another at about 5 years of age. There are now pertussis vaccines available for use in adults (Repevax). Some countries are recommending a booster shot at 10 year intervals throughout life. There is a problem however. The vaccine is against pertussis, diphtheria, tetanus and polio. It can be fine to give this once every 10 years, but it cannot be used to immunise people who have never has pertussis immunization because 3 shots are required and that would run the risk of a reaction to one or more of the other components. A vaccine to pertussis alone would help to fill the gap, but so far there is no such vaccine available. There is also considerable doubt about whether repeated boosters will prevent spread, given that natural reinfection and probable boosting is quite common. Much research is ongoing in this area.